# US 2008/0305504 A1 · Compositions, methods, and kits for assaying complement activation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305504 A1
- Document ID: US20080305504A1
- Status: Published application
- Kind: A1
- Application number: 11/811,425
- Filed: 2007-06-08
- Published: 2008-12-11
- Earliest claimed: 2007-06-08
- Assignees: General Electric Company
- Inventors: Liming Yu; Anup Sood; Mark Felipe Baptista
- Web page: https://patentgrep.com/patent/US20080305504A1

## CPC

- C07K 14/472: {Complement proteins, e.g. anaphylatoxin, C3a, C5a}
- C12Q 1/37: involving peptidase or proteinase
- G01N 2333/96441: with definite EC number
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a fluorogenic composition for assaying complement activation that comprises a substrate for C3 convertase that is linked to a first fluorophore and a second fluorophore, wherein the fluorescence of the first and second fluorophores are mutually substantially quenched when the two fluorophores are present at a distance less than the characteristic distance for the two fluorophores. In one embodiment, the fluorescence of the first fluorophore is substantially quenched by the second fluorophore, and the second fluorophore emits heat upon quenching. The present invention also provides a method for assaying complement activation, wherein the method includes the steps of incubating a biological sample with a polymer to provide a polymeric biological sample, followed by incubating the polymeric biological sample with the fluorogenic composition, and measuring the fluorescence. The method may optionally include the step of measuring the optical properties of the biological sample prior to the incubation steps. The present invention further provides a kit for assaying complement activation that comprises the fluorogenic composition disclosed herein.

## Claims

### Claim 1

A fluorogenic composition comprising a peptide substrate for C3 convertase linked to a first fluorophore and a second fluorophore at a characteristic distance wherein the fluorescences of the first and second fluorophores are mutually substantially quenched.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the fluorescence of the first fluorophore is substantially quenched by the second fluorophore.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the second fluorophore emits heat upon quenching.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the peptide substrate comprises a polypeptide having at least 10 amino acid residues.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the peptide substrate comprises a polypeptide encoded by sequence identified as SEQ ID NO.: 1.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the first fluorophore and the second fluorophore are of the same species.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the first fluorophore and the second fluorophore are of a different species.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the first fluorophore/second fluorophore absorbs at a wavelength greater than about 600 nm.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the first fluorophore is a Cy5 dye, and the second fluorophore is a Cy7Q dye.

### Claim 10

A method of assaying complement activation in a biological sample, comprising the steps:
(a) providing a biological sample having optical properties;
(b) optionally measuring the optical properties of the biological sample;
(c) incubating the biological sample with a material to provide an activated biological sample;
(d) incubating the activated biological sample with a fluorogenic composition capable of producing a detectable signal, wherein the fluorogenic composition comprises a substrate for C3 convertase, wherein the substrate is linked to a first fluorophore and a second fluorophore; wherein the fluorescence of the first and second fluorophores are mutually substantially quenched when the first and second fluorphores are present at a distance less than a characteristic distance for the two fluorophores; and
(e) measuring the detectable signal.

### Claim 11 (depends on 10)

The method of claim 10, wherein the fluorescence of the first fluorophore is substantially quenched by the second fluorophore.

### Claim 12 (depends on 11)

The method of claim 11, wherein the second fluorophore emits heat upon quenching.

### Claim 13 (depends on 10)

The method of claim 10, wherein the peptide substrate comprises a polypeptide having at least 10 amino acid residues.

### Claim 14 (depends on 13)

The method of claim 13, wherein the peptide substrate comprises a polypeptide encoded by sequence identified as SEQ ID NO.: 1.

### Claim 15 (depends on 10)

The method of claim 10, wherein the first fluorophore and second fluorophore are attached to the terminal ends of the peptide substrate.

### Claim 16 (depends on 10)

The method of claim 10, wherein the first fluorophore and second fluorophore are of the same species.

### Claim 17 (depends on 10)

The method of claim 10, wherein the first fluorophore and the second fluorophore are of a different species.

### Claim 18 (depends on 10)

The method of claim 10, wherein the first fluorophore absorbs at a wavelength greater than about 600 nm.

### Claim 19 (depends on 10)

The method of claim 10, wherein the first fluorophore is a Cy5 dye, and the second fluorophore is a Cy7Q dye.

### Claim 20 (depends on 10)

The method of claim 10, wherein the material activates the non-classical complement activation pathway.

### Claim 21 (depends on 10)

The method of claim 10, wherein the material is a polymeric material.

### Claim 22 (depends on 10)

The method of claim 10, wherein only steps (a), (b), (d) and (e) are performed.

### Claim 23 (depends on 10)

The method of claim 10, wherein the biological sample is optionally processed to substantially deplete agents that participate in classical complement activation pathway after performing step (b).

### Claim 24 (depends on 10)

The method of claim 10, wherein the incubating is performed for a time period ranging from about 30 minutes to about 24 hours.

### Claim 25 (depends on 10)

The method of claim 10, wherein the incubating is performed at a temperature ranging from about 4° C. to about 50° C.

### Claim 26 (depends on 10)

The method of claim 10, wherein the incubating is performed at a temperature ranging from about 10° C. to about 40° C.

### Claim 27 (depends on 10)

The method of claim 10, wherein the incubating is performed at a temperature ranging from about 25° C. to about 37° C.

### Claim 28 (depends on 10)

The method of claim 10, wherein the biological sample is derived from a sample that is selected from tissue or blood.

### Claim 29 (depends on 10)

The method of claim 10, wherein the biological sample is derived from pooled normal mammalian plasma.

### Claim 30 (depends on 10)

The method of claim 10, wherein the detectable signal is measured by fluorescence spectroscopy.

### Claim 31

A kit for assaying complement activation in a biological sample comprising a fluorogenic composition comprising a substrate for C3 convertase that is linked to a first fluorophore and a second fluorophore; wherein the fluorescences of the first and second fluorophores are mutually substantially quenched when the first and second fluorphores are present at a distance less than a characteristic distance for the two fluorophores.

### Claim 32 (depends on 31)

The kit of claim 31, wherein the fluorescence of the first fluorophore is substantially quenched by the second fluorophore.

### Claim 33 (depends on 31)

The kit of claim 31, wherein the second fluorophore emits heat upon quenching.

### Claim 34 (depends on 31)

The kit of claim 31, wherein the substrate comprises a sequence having at least 10 residues.

### Claim 35 (depends on 34)

The kit of claim 34, wherein the peptide substrate comprises a polypeptide encoded by sequence identified as SEQ ID NO.: 1.

### Claim 36 (depends on 31)

The kit of claim 31, wherein the first and second fluorophore are of the same species.

### Claim 37 (depends on 31)

The kit of claim 31, wherein the first fluorophore and second fluorophore are of a different species.

### Claim 38 (depends on 31)

The kit of claim 31, wherein the first fluorophore is a Cy5 dye, and the second fluorophore is a Cy7Q dye.

### Claim 39 (depends on 31)

The kit of claim 31, wherein the biological sample is selected from tissue or blood.

### Claim 40 (depends on 31)

The kit of claim 31, wherein the biological sample is derived from pooled normal mammalian plasma.

### Claim 41 (depends on 31)

The kit of claim 31, further comprising a material that is used to activate non-classical complement activation pathway in the biological sample.

### Claim 42 (depends on 41)

The kit of claim 41, wherein the material is a polymeric material.

### Claim 43 (depends on 31)

The kit of claim 31, further comprising a medium suitable for incubating the biological sample.

### Claim 44 (depends on 31)

The kit of claim 31, wherein the detectable signal is detected by fluorescence spectroscopy.
